DNTH – Dianthus Therapeutics Inc
Investors holding2
Combined shares118,280
Combined reported value$10.4M
DNTH chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| Paul Tudor Jones narrow view | 0.04 | Added 150.2% | 93,353 | $8.2M | Q3 2026 |
| Polen Capital | 0.02 | Added 167.1% | 24,927 | $2.2M | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Paul Tudor Jones narrow view | Added 150.2% | 93,353 | 0.02 |
| Q3 2026 | Polen Capital | Added 167.1% | 24,927 | 0.01 |
| Q2 2026 | Paul Tudor Jones narrow view | New | 37,308 | 0.02 |
| Q2 2026 | Polen Capital | Added 126.6% | 9,333 | 0.00 |
| Q1 2026 | Polen Capital | New | 4,119 | 0.00 |
Added: opened or increased
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Paul Tudor Jones narrow view | Added 150.2% | 93,353 | 0.02 |
| Q3 2026 | Polen Capital | Added 167.1% | 24,927 | 0.01 |
| Q2 2026 | Paul Tudor Jones narrow view | New | 37,308 | 0.02 |
| Q2 2026 | Polen Capital | Added 126.6% | 9,333 | 0.00 |
| Q1 2026 | Polen Capital | New | 4,119 | 0.00 |
Reduced: reduced or closed
No tracked investor reduced or closed this position in the last 4 quarters.
History
2 peakQ3 2026: 2 tracked investors
20262026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Paul Tudor Jones | 93.4K | 37.3K | – | – | – | – | – | – |
| Polen Capital | 24.9K | 9.3K | 4.1K | – | – | – | – | – |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).